Viatris (VTRS) EBIT (QoQ) (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.55 Bn | 38.89 Bn | 2.15 Bn |
| 2 | Viatris | 19.15 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.32 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 401.76 Mn | 360.51 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.90% |
| Mar 31, 2026 | 58.64% |
| Dec 31, 2025 | -207.77% |
| Sep 30, 2025 | -23.26% |
| Jun 30, 2025 | 108.08% |
| Mar 31, 2025 | -1,503.00% |
| Dec 31, 2024 | -179.59% |
| Sep 30, 2024 | 194.16% |
| Jun 30, 2024 | -217.66% |
| Mar 31, 2024 | 144.86% |
| Dec 31, 2023 | -200.62% |
| Sep 30, 2023 | 22.35% |
| Jun 30, 2023 | -7.65% |
| Mar 31, 2023 | 298.61% |
| Dec 31, 2022 | -135.94% |
| Sep 30, 2022 | 2.08% |
| Jun 30, 2022 | -22.43% |
| Mar 31, 2022 | 1,011.60% |
| Dec 31, 2021 | -121.70% |
| Sep 30, 2021 | 848.12% |